Skip to main content

For community pharmacy

Keep medicine changes, supply signals and hand-offs from disappearing between teams.

A discovery route for community-pharmacy leaders who can identify a bounded medicines workflow, the local barrier and the accountable hand-off that needs clearer evidence.

Route | Discovery and problem qualificationScope | Non-confidential workflow evidence onlyBoundary | No live stock, prescribing or NHS integration claim

Where work fragments

The local problem is often the hand-off, not the absence of another dashboard.

Medicine changes, supply disruption, referrals and service acknowledgements can cross professional and organisational boundaries. A discovery conversation tests whether one failure pattern can be defined and owned without pretending to provide real-time stock or clinical authority.

01

Change

A medicine or pathway changes, but the operational consequence is unclear.

02

Signal

A supply or service issue is visible locally but lacks a reviewable escalation path.

03

Hand-off

An action moves between pharmacy, practice, commissioner or supplier without acknowledgement.

What to share

One organisation type, one workflow and one non-confidential barrier.

Useful context includes the role involved, the trigger, current hand-off, responsible decision, known blockers and what a better process would make observable. Do not submit patient information, credentials, contracts or live security details.

Human decision requiredProceed only inside an evidenced and governed scope.
  • 01

    Trigger

    What event starts the work?

  • 02

    Owner

    Who can decide or escalate?

  • 03

    Failure

    Where does the acknowledgement, evidence or action currently stop?

  • 04

    Measure

    What would show that the hand-off improved?

Current boundary

Discovery is not an integration, customer or service announcement.

NEUVIOR does not claim access to NHS medicines-supply tools, real-time pharmacy stock, prescribing systems or patient records. PHARMORIS remains in controlled, non-production development.

Questions and boundaries

Useful questions before we start.

01Is this a live pharmacy service?

No. It is a discovery route for qualifying a repeated, non-confidential medicines workflow problem.

02Does PHARMORIS connect to pharmacy stock or NHS systems?

No live stock, prescribing, NHS supply-tool or patient-record integration is claimed.

03What makes a useful discovery question?

A repeated trigger, a named hand-off or decision owner, a visible failure and an observable measure of improvement.

Help falsify the problem

Is there one repeated medicines hand-off worth examining?

Describe the non-confidential failure pattern and who currently owns the next decision.

Human decision requiredProceed only inside an evidenced and governed scope.